How well a patient can count, remember word lists, or perform other basic tests may not indicate how far Alzheimer's dementia has progressed biologically, researchers said at the RSNA meeting.
How well a patient can count, remember word lists, or perform other basic tests may not indicate how far Alzheimer's dementia has progressed biologically, researchers said at the RSNA meeting.
The Mini-Mental Status Exam has been the standard diagnostic tool for Alzheimer's disease for years, relying on a series of simple cognitive tests to calculate a score for degree of mental impairment. In 58 patients who also underwent PET or SPECT imaging, however, the MMSE showed little correlation with imaging evidence of advanced disease.
Many patients with near-normal MMSE scores showed pronounced bilateral defects on imaging, while others with extremely low MMSE scores showed only moderate PET or SPECT perfusion defects, according to Amitha Rao, a third-year medical student at the University of Kansas, who completed the research under the direction of radiologist Dr. Reginald Dusing.
Patients were excluded from the study if they showed evidence of non-Alzheimer's dementias, vascular defects, or other conditions that could mimic symptoms or invalidate imaging findings. Two readers, board-certified in both radiology and nuclear medicine, interpreted the studies.
The lack of correlation between the two types of tests adds muscle to the theory that adding PET or SPECT may speed the diagnosis of Alzheimer's, Rao said.
PET has secured limited Medicare reimbursement as an imaging agent in dementia cases, but only to rule out non-Alzheimer's dementias that can not be distinguished clinically from Alzheimer's.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.